CCR2 improves tumor directed CAR-T cell trafficking in ovarian cancer
Raj Kumar(Brigham and Women's Hospital), Oladapo Yeku(Harvard University)
Cited by 1
Related Papers
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
|Nature Medicine|2018|1k
Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
|Scientific Reports|2017|397
Hypoxia induced VEGF secretion promotes resistance to bispecific T-cell engagers
|Signal Transduction and Targeted Therapy|2025|2